Medtronic nets FDA approval of new connector system for ICDs, CRT-Ds

Medtronic has received FDA approval and launched its DF4 High-Voltage Connector system, a right ventricular lead and connector used with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

The DF4 connector uses the same lead body as Medtronic’s Sprint Quattro lead, and the DF4 design includes fewer connections between the device and the defibrillation leads, according to the Minneapolis-based company. The DF4 connector has a single set-screw to connect the lead to the device and is available on several Medtronic ICDs and CRT-Ds, including the Protecta, Consulta and Secura portfolio of implantable defibrillators.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.